Transenterix Inc (NASDAQ:TRXC) shares were up 17.4% during mid-day trading on Monday . The company traded as high as $1.01 and last traded at $1.01. Approximately 1,452,913 shares changed hands during trading, an increase of 40% from the average daily volume of 1,039,300 shares. The stock had previously closed at $0.86.

A number of research analysts have recently issued reports on TRXC shares. Zacks Investment Research upgraded shares of Transenterix from a “hold” rating to a “buy” rating and set a $0.75 price objective for the company in a report on Wednesday, May 10th. B. Riley cut shares of Transenterix to a “neutral” rating and set a $0.70 price objective for the company. in a report on Tuesday, May 16th.

The stock’s 50-day moving average price is $0.75 and its 200 day moving average price is $0.84. The firm’s market capitalization is $145.57 million.

Institutional investors have recently modified their holdings of the stock. Global X Management Co. LLC increased its stake in shares of Transenterix by 238.3% in the 2nd quarter. Global X Management Co. LLC now owns 331,075 shares of the company’s stock worth $235,000 after acquiring an additional 233,213 shares in the last quarter. Royal Bank of Canada increased its stake in shares of Transenterix by 17.1% in the 2nd quarter. Royal Bank of Canada now owns 418,867 shares of the company’s stock worth $298,000 after acquiring an additional 61,034 shares in the last quarter. Goldman Sachs Group Inc. increased its stake in shares of Transenterix by 7,137.7% in the 2nd quarter. Goldman Sachs Group Inc. now owns 1,203,199 shares of the company’s stock worth $854,000 after acquiring an additional 1,186,575 shares in the last quarter. UBS Oconnor LLC bought a new position in shares of Transenterix in the 2nd quarter worth about $390,000. Finally, LMR Partners LLP bought a new position in shares of Transenterix in the 2nd quarter worth about $189,000.

ILLEGAL ACTIVITY WARNING: This report was first reported by Daily Political and is the sole property of of Daily Political. If you are reading this report on another website, it was illegally copied and reposted in violation of US & international trademark and copyright laws. The original version of this report can be accessed at https://www.dailypolitical.com/2017/09/06/transenterix-inc-trxc-trading-up-17-4.html.

Transenterix Company Profile

TransEnterix, Inc is a medical device company. The Company is focused on the development and commercialization of ALF-X Surgical Robotic System (the ALF-X System), and SurgiBot System. The Company’s ALF-X System is a multi-port robotic surgery system, which allows multiple robotic arms to control instruments and a camera.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.